Amgen gains 1st US CV drug OK with Corlanor
This article was originally published in Scrip
Executive Summary
Amgen gained its first US cardiovascular drug approval on 15 April with the FDA giving its nod to the firm's heart failure medicine Corlanor (ivabradine).